Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Teva’s anti-CGRP drug Ajovy cleared for migraine prevention

pharmatimesSeptember 18, 2018

Tag: teva , Migraine , CGRP

PharmaSources Customer Service